Synthesis and evaluation of a conditionally-silent agonist for the α7 nicotinic acetylcholine receptor

被引:36
|
作者
Chojnacka, Kinga [1 ]
Papke, Roger L. [2 ]
Horenstein, Nicole A. [1 ]
机构
[1] Univ Florida, Dept Chem, Gainesville, FL 32611 USA
[2] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
关键词
Silent-agonist; Allosteric modulator; Ion-channel; Nicotinic receptor; POSITIVE ALLOSTERIC MODULATION; ACTIVATION; MECHANISM; LIGANDS; CHANNEL;
D O I
10.1016/j.bmcl.2013.05.039
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We introduce the term 'silent agonists' to describe ligands that can place the alpha 7 nicotinic acetylcholine receptor (nAChR) into a desensitized state with little or no apparent activation of the ion channel, forming a complex that can subsequently generate currents when treated with an allosteric modulator. KC-1 (5'-phenylanabaseine) was synthesized and identified as a new silent agonist for the alpha 7 nAChR; it binds to the receptor but does not activate alpha 7 nAChR channel opening when applied alone, and its agonism is revealed by co-application with the type II positive allosteric modulator PNU-120596 in the Xenopus oocyte system. The concise synthesis was accomplished in three steps with the C-C bonds formed via Pd-catalyzed mono-arylation and organolithium coupling with N-Boc piperidinone. Comparative structural analyses indicate that a positive charge, an H-bond acceptor, and an aryl ring in a proper arrangement are needed to constitute one class of silent agonist for the alpha 7 nAChR. Because silent agonists may act on signaling pathways not involving ion channel opening, this class of alpha 7 nAChR ligands may constitute a new alternative for the development of alpha 7 nAChR therapeutics. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4145 / 4149
页数:5
相关论文
共 50 条
  • [1] Binding Interactions of NS6740, a Silent Agonist of the α7 Nicotinic Acetylcholine Receptor
    Blunt, Catriona E. W.
    Dougherty, Dennis A.
    MOLECULAR PHARMACOLOGY, 2019, 96 (02) : 212 - 218
  • [2] Synthesis and preliminary evaluation of a carbon-11-labelled agonist of the α7 nicotinic acetylcholine receptor
    Dolle, F
    Valette, H
    Hinnen, F
    Vaufrey, F
    Demphel, S
    Coulon, C
    Ottaviani, M
    Bottlaender, M
    Crouzel, C
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2001, 44 (11): : 785 - 795
  • [3] NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity
    Papke, Roger L.
    Peng, Can
    Kumar, Ashok
    Stokes, Clare
    NEUROSCIENCE LETTERS, 2018, 677 : 6 - 13
  • [4] Silent agonists for alpha7 nicotinic acetylcholine receptor
    Chojnacka, Kinga
    Papke, Roger L.
    Horenstein, Nicole A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [5] The Minimal Pharmacophore for Silent Agonism of the α7 Nicotinic Acetylcholine Receptor
    Papke, Roger L.
    Chojnacka, Kinga
    Horenstein, Nicole A.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (03): : 665 - 680
  • [6] Development of an Efficient Synthesis of an Agonist of Acetylcholine Nicotinic Receptor
    Hardouin, Christophe
    Poixblanc, Aurelie
    Bariere, Francois
    Tamion, Rodolphe
    Dubuffet, Thierry
    Hervouet, Yvon
    Mouchet, Patrick
    ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2018, 22 (10) : 1419 - 1425
  • [7] Agonist activation of a nicotinic acetylcholine receptor
    Auerbach, Anthony
    NEUROPHARMACOLOGY, 2015, 96 : 150 - 156
  • [8] Concise Synthesis of JN403, a Novel Nicotinic Acetylcholine Receptor 7 Selective Agonist
    Jiang, Xinglong
    Prasad, Kapa
    Repic, Oljan
    SYNTHETIC COMMUNICATIONS, 2009, 39 (15) : 2640 - 2646
  • [9] Metabolism and disposition of a selective α7 nicotinic acetylcholine receptor agonist in humans
    Shaffer, Christopher L.
    Gunduz, Mithat
    Scialis, Renato J.
    Fang, Annie F.
    DRUG METABOLISM AND DISPOSITION, 2007, 35 (07) : 1188 - 1195
  • [10] Silent agonists for α7 nicotinic acetylcholine receptors
    Papke, Roger L.
    Quadri, Marta
    Gulsevin, Alican
    PHARMACOLOGICAL RESEARCH, 2023, 190